Farther Finance Advisors’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$154K Sell
608
-151
-20% -$37.6K ﹤0.01% 2208
2025
Q4
$209K Buy
759
+106
+16% +$29K ﹤0.01% 1891
2025
Q3
$171K Sell
653
-8
-1% -$1.94K ﹤0.01% 1699
2025
Q2
$145K Sell
661
-103
-13% -$22K ﹤0.01% 1563
2025
Q1
$168K Sell
764
-214
-22% -$59K ﹤0.01% 1296
2024
Q4
$320K Buy
978
+54
+6% +$17K 0.01% 780
2024
Q3
$278K Sell
924
-635
-41% -$194K 0.01% 862
2024
Q2
$506K Buy
1,559
+1,163
+294% +$411K 0.02% 478
2024
Q1
$157K Buy
396
+90
+29% +$33.3K 0.01% 777
2023
Q4
$108K Buy
306
+71
+30% +$25.1K 0.01% 779
2023
Q3
$88.2K Buy
235
+8
+4% +$3.09K 0.01% 604
2023
Q2
$86.8K Buy
227
+50
+28% +$17.9K 0.02% 504
2023
Q1
$61.3K Sell
177
-18
-9% -$5.26K 0.02% 547
2022
Q4
$45.9K Buy
+195
New +$46.2K 0.02% 511

Other funds holding WST